Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.
Most participants first33,758 with no events in either group come last841 to 860 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| Open Group vs Masked Group: Number of Neonates With Shoulder Dystocia During Delivery | 141 of 5,532 158 of 5,576 | -0.3 points -0.9 to 0.3 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Neonatal Deaths (Primary Outcome Component) | 3 of 5,532 1 of 5,576 | 0.0 points -0.1 to 0.1 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Participants Who Had a Postpartum Blood Transfusion | 80 of 5,532 74 of 5,576 | 0.1 points -0.3 to 0.6 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Infants With Meconium Aspiration Syndrome | 20 of 5,532 20 of 5,576 | 0.0 points -0.2 to 0.2 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Participants With Primary Composite Outcome | 52 of 5,532 40 of 5,576 | 0.2 points -0.1 to 0.6 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Participants With Chorioamnionitis | 286 of 5,532 269 of 5,576 | 0.3 points -0.5 to 1.2 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Neonates Intubated for Ventilation at Delivery (Primary Outcome Component) | 42 of 5,532 27 of 5,576 | 0.3 points -0.0 to 0.6 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Infants With a Major Congenital Malformation | 38 of 5,532 23 of 5,576 | 0.3 points -0.0 to 0.6 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Participants Experiencing Postpartum Endometritis | 71 of 5,532 88 of 5,576 | -0.3 points -0.7 to 0.1 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Infants Who Experienced Neonatal Seizure (Primary Outcome Component) | 3 of 5,532 4 of 5,576 | -0.0 points -0.1 to 0.1 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: Number of Infants Admitted to Special Care Nursery | 498 of 5,532 470 of 5,576 | 0.6 points -0.5 to 1.6 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Open Group vs Masked Group: serious adverse events | 35 of 5,532 21 of 5,576 | 0.3 points -0.0 to 0.5 | 11,108 | NCT01131260 Fetal ST Segment and T Wave Analysis in Labor |
| Cangrelor Treatment Arm vs Clopidogrel Treatment Arm: serious adverse events | 122 of 5,529 105 of 5,527 | 0.3 points -0.2 to 0.8 | 11,056 | NCT01156571 A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX) |
| TICAGRELOR vs PLACEBO: ICH or Fatal Bleeding Event | 22 of 5,523 6 of 5,493 | 0.3 points 0.1 to 0.5 | 11,016 | NCT03354429 THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death |
| TICAGRELOR vs PLACEBO: Premature Permanent Discontinuation of IP Due to Bleeding | 152 of 5,523 32 of 5,493 | 2.2 points 1.7 to 2.7 | 11,016 | NCT03354429 THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death |
| TICAGRELOR vs PLACEBO: Bleeding Event That Fulfils Serious Adverse Event Criteria and is Categorised as GUSTO Severe | 28 of 5,523 7 of 5,493 | 0.4 points 0.2 to 0.6 | 11,016 | NCT03354429 THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death |
| TICAGRELOR vs PLACEBO: Bleeding Event That Fulfils Serious Adverse Event Criteria and is Categorised as GUSTO Moderate/Severe | 36 of 5,523 11 of 5,493 | 0.5 points 0.2 to 0.7 | 11,016 | NCT03354429 THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death |
| TICAGRELOR vs PLACEBO: Ischaemic Stroke | 276 of 5,523 345 of 5,493 | -1.3 points -2.1 to -0.4 | 11,016 | NCT03354429 THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death |
| TICAGRELOR vs PLACEBO: Composite of Subsequent Stroke or Death | 303 of 5,523 362 of 5,493 | -1.1 points -2.0 to -0.2 | 11,016 | NCT03354429 THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death |
| Ticagrelor vs Placebo: deaths from any cause | 40 of 5,523 32 of 5,493 | 0.1 points -0.2 to 0.5 | 11,016 | NCT03354429 THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death |
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=43
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT01131260-0ce0d8c7",
"title": "Open Group vs Masked Group: Number of Neonates With Shoulder Dystocia During Delivery",
"summary": "141 of 5532 against 158 of 5576; risk difference -0.3 points, 95% interval -0.9 to 0.3; NCT01131260, Fetal ST Segment and T Wave Analysis in Labor",
"record": "/library/comparisons/NCT01131260-0ce0d8c7",
"nct_id": "NCT01131260",
"kind": "outcome",
"participants": 11108,
"risk_difference": {
"value": -0.002847655119399224,
"lower": -0.00890665441256894,
"upper": 0.0031960270334231234
},
"group_1": "141 of 5,532",
"group_2": "158 of 5,576",
"difference": "-0.3 points",
"interval": "-0.9 to 0.3",
"trial_title": "Fetal ST Segment and T Wave Analysis in Labor"
},
{
"id": "NCT01131260-1f9a450c",
"title": "Open Group vs Masked Group: Number of Neonatal Deaths (Primary Outcome Component)",
"summary": "3 of 5532 against 1 of 5576; risk difference 0.0 points, 95% interval -0.1 to 0.1; NCT01131260, Fetal ST Segment and T Wave Analysis in Labor",
"record": "/library/comparisons/NCT01131260-1f9a450c",
"nct_id": "NCT01131260",
"kind": "outcome",
"participants": 11108,
"risk_difference": {
"value": 0.0003629593205463763,
"lower": -0.0005463073646726211,
"upper": 0.0014243083597192056
},
"group_1": "3 of 5,532",
"group_2": "1 of 5,576",
"difference": "0.0 points",
"interval": "-0.1 to 0.1",
"trial_title": "Fetal ST Segment and T Wave Analysis in Labor"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "None stated"
}
],
"next": "/api/comparisons/v1?page=44",
"request_id": "jJ7ak14BHPqgfIZA"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant